Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: A long-term prospective study

By Klarskov Louise L.  

Scandinavian Journal of Urology and Nephrology, Vol. 46, Iss. 1, 2012-02 ,pp. : 37-43

Informa Healthcare

Access to resources Recommend Favorite

Urinary Excretion of Calcitonin Gene-related Peptide in Males with Hot Flushes after Castration for Carcinoma of the Prostate

By Wyon Yvonne   Spetz Anna-Clara   Hammar Mats   Theodorsson Elvar   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 35, Iss. 2, 2001-03 ,pp. : 92-96

Informa Healthcare

Access to resources Recommend Favorite

Treatment of localized prostate cancer

By Burchardt Martin   Huland Hartwig  

World Journal of Urology, Vol. 25, Iss. 1, 2007-03 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer treatment

By Dehn Tom  

Annals of The Royal College of Surgeons of England, Vol. 88, Iss. 5, 2006-09 ,pp. : 439-444

The Royal College of Surgeons of England

Access to resources Recommend Favorite

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists

By Koch M.   Steidle C.   Brosman S.   Centeno A.   Gaylis F.   Campion M.   Garnick M.B.   ABARELIX STUDY GROUP  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 877-882

Elsevier

Access to resources Recommend Favorite